Abstract:Background Sarcopenia is an age-related condition that causes loss of skeletal muscle mass and disability. Sarcopenia is closely related to the prognosis of patients suffering osteoporotic thoraco-lumbar compression fractures (OTLCF). The purpose of this study was to investigate the effect of sarcopenia on the efficacy of percutaneous kyphoplasty (PKP) in the treatment of older adults with OTLCF surgery and postoperative mortality. Methods From February 2016 to June 2019, 101 patients who met the inclusion and exclusion criteria were included in this study. The grip strength of the dominant hand was measured using an electronic grip tester. The diagnostic cutoff value of grip strength for sarcopenia was <27 kg for males and <16 kg for females. The cross-sectional area (cm 2 ) of the musculature at the level of the pedicle of the thoracic 12th vertebra (T12) was measured by chest CT. The skeletal muscle index (SMI) was calculated by dividing the muscle cross-sectional area at the T12 pedicle level by the square of the height. The diagnostic cut-off value of SMI at T12 level is 42.6 cm 2 /m 2 for males and 30.6 cm 2 /m 2 for females. Sarcopenia was diagnosed when the grip strength and SMI values were both lower than the diagnostic cut-off value. All included patients received PKP treatment for OTLCF. The age, gender, operation time, bleeding volume, time to ground, length of hospital stay, visual analog scale (VAS) score before operation and one month after operation, Oswestry Disability Index (ODI) one month after operation and the incidence of refracture within 36 months after operation were compared between the two groups. The survival curves of the two groups were analyzed by Kaplan Meier. Chi-square test was used to compare the differences in survival rates between the two groups at 12, 24, and 36 months after operation. Univariate and multivariate Cox regression analysis compared multivariate factors on OTLCF postoperative mortality. Results There was no significant difference in gender, operation time, blood loss and preoperative VAS score between the two groups ( χ 2 = 1.750, p = 0.186; t = 1.195, p = 0.235; t = −0.582, p = 0.562; t = −1.513, p = 0.133), respectively. The patients in the sarcopenia group were older ( t = 3.708, p = 0.000), and had longer postoperative grounding time and hospitalization time ( t = 4.360, p = 0.000; t = 6.458, p = 0.000). The VAS scores and ODI scores one month postoperatively were also higher in sarcopenia group ( t = 5.900, p = 0.000; t = 7.294, p = 0.000), and there was a statistical difference between the two groups. Interestingly, there was no significant difference in the incidence of spinal refracture within 36 months between the two groups ( χ 2 = 1.510, p = 0.219). The sarcopenia group had a higher mortality rate at 36 months after operation, and the difference was statistically significant ( p = 0.002). Sarcopenia is an independent risk factor for long-term mortality in OTLCF patients received PKP surgery. Conclusions Patients with sarcopenia combined with OTLCF have poor postoperative recovery of limb function and a high risk of death in the long-term (36 months) after surgery. Active and effective intervention for sarcopenia is required during treatment.

Sarcopenia is a possible risk factor for amputation after peripheral arterial interventions

The Impact of Sarcopenia in the Long-Term Survival of Patients following Complex Endovascular Aortic Surgery for Thoracoabdominal Aortic Aneurysms

Sarcopenia is associated with lower step count in patients with peripheral artery disease following endovascular treatment

Clinical impact of Sarcopenia on long-term mortality in patients undergoing coronary bypass grafting

Effect of sarcopenia on mortality in acute stroke patients receiving endovascular treatment

Sarcopenia adversely impacts clinical outcomes in patients undergoing pancreaticoduodenectomy: A systematic review and meta-analysis

The Negative Impacts of Sarcopenia on Primary Total Knee Arthroplasty under the Enhanced Recovery after Surgery Protocol

The Impact of Body Composition on Mortality and Hospital Length of Stay after Endovascular and Open Aortic Aneurysm Repair: A Retrospective Cohort Study

Impact of sarcopenia on outcomes following intra-arterial therapy of hepatic malignancies

Influence of sarcopenia on surgical efficacy and mortality of percutaneous kyphoplasty in the treatment of older adults with osteoporotic thoracolumbar fracture

#3007 Association between sarcopenia and clinical outcomes in patients on maintenance hemodialysis

Influence of sarcopenia on postoperative complications and long-term survival in pancreatic cancer patients undergone pancreaticoduodenectomy

Sarcopenia Predicts Adverse Outcomes in an Elderly Population with Coronary Artery Disease: a Systematic Review and Meta-Analysis

Prognostic Value of Sarcopenia in Older Adults with Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis

Sarcopenia Is Associated With Increased Mortality in Patients With Necrotizing Soft Tissue Infections

Sarcopenia influences usage of reperfusion treatment in patients with pulmonary embolism aged 75 years and older

Thoracic sarcopenia measured by Hounsfield unit average calculation predicts morbidity and mortality in coronary artery bypass grafting

Association of sarcopenia, as defined based on the skeletal muscle index, with mortality and morbidity after cardiac surgery: a retrospective cohort study

Sarcopenia As a Determinant Prognostic Factor After Surgery Among Patients with Colorectal Cancer

Association of endothelial dysfunction and peripheral arterial disease with sarcopenia in chronic kidney disease

Sarcopenia predicts perioperative adverse events following complex revision surgery for the thoracolumbar spine